|Day Low/High||90.67 / 90.81|
|52 Wk Low/High||60.10 / 98.60|
Medidata (NASDAQ: MDSO) today announced that it will release its second quarter 2019 results after the close of U.
Medidata (NASDAQ: MDSO) announced today that Catalyst Clinical Research chose the Medidata Rave Clinical Cloud™ for its one-platform approach to clinical trials.
Medidata (NASDAQ: MDSO) announced that TissueTech, Inc. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform for clinical trials.
Former Attorney General of Louisiana Charles C. Foti, Jr.
Medidata (NASDAQ: MDSO) today announced that global pharmaceutical company Orion will consolidate all clinical trials on the Medidata Rave Clinical Cloud™ and expand its use of trial management solutions to support growth of its R&D pipeline.
NEW YORK, June 18, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Medidata Solutions, Inc.
NEW YORK, June 14, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: Raytheon Company ( RTN )...
Stocks end lower as Wall Street worries about a U.S.-China trade agreement in the near term.
NEW YORK, June 12, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Medidata Solutions, Inc.
Medidata Solutions shares traded lower Wednesday after it agreed a takeover offer from France's Dassault Systemes SE at a discount to its current market value.
SAN DIEGO, June 12, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Medidata Solutions, Inc.
Global stocks stalled Wednesday, pulling Wall Street futures modestly into the red, as investors pared recent equity market gains amid concerns over the strength of the world economy and the fate of U.S.-China trade talks.
U.S. stock futures decline as optimism fades over a near-term trade deal between Washington and Beijing; Tesla CEO Elon Musk says there's a 'decent shot of a record quarter' for the electric vehicle maker; France's Dassault Systemes to buy Medidata Solutions for $5.8 billion.
Dassault Systèmes (Euronext Paris: #13065, DSY.PA) and Medidata Solutions, Inc.
Medidata (NASDAQ:MDSO) announced today that the Medidata Institute is working with industry partners to deliver insights that redefine how technology, data and AI can improve lives and inspire the next generation of medical treatments.
Medidata (NASDAQ:MDSO) announced today that it has been named a Leader in the Everest Group's 2019 Life Sciences Clinical Trials Products PEAK Matrix, based upon market impact, plus vision and capability.
Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019, at 9 a.
For the third consecutive year, Medidata (NASDAQ: MDSO) will present breakthrough scientific findings at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Medidata (NASDAQ:MDSO) is pleased to announce that Jackie Kent was named a "Luminary" and Katrina Weigold a "Rising Star" by the Healthcare Businesswomen's Association (HBA).
Medidata (NASDAQ: MDSO) today announced that Tarek Sherif, chairman and chief executive officer, will present at the 47th Annual J.
Medidata (NASDAQ: MDSO) won a Gold Stevie Award in the 'Corporate Social Responsibility Program of the Year' category at the 17 th Annual American Business Awards.
Medidata (NASDAQ: MDSO) today announced that medical technology business Smith & Nephew (LSE: SN, NYSE: SNN) has consolidated all of its global studies on the Medidata Rave Clinical Cloud.
Medidata (NASDAQ: MDSO) today announced its financial results for the first quarter of 2019.
Medidata (NASDAQ: MDSO) corporate social responsibility (CSR) and diversity and belonging programs continue to earn honors as they make a difference for patients, employees, and the environment.
Is this just some routine consolidation after a big run or is it an indicator of further weakness ahead?
Medidata (NASDAQ:MDSO) today announced that it will release its first quarter 2019 financial results before the market opens on Tuesday, April 30, 2019.
Medidata Solutions (NASDAQ: MDSO) is taking the next significant step to accelerate the digital transformation of life sciences in the age of precision medicine.
Ark Invest has developed a series of specialized exchange-traded funds that own shares in companies involved in 'disruptive innovation.'
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCEI, CHU, CNNE, GHL, GIS, MDSO, NCMI, RDNT, STN, TUP Downgrades: CDEV, HCSG, NCI, PTEN, RRGB Initiations: PPDF Read on to get TheStreet Quant Ratings' detailed report:
SHYFT Analytics, a Medidata company (NASDAQ: MDSO), today announced that it has significantly enhanced the real-world evidence (RWE) components of its solution platform.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.